Colchicine Versus Placebo in Acute Myocarditis Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT05855746

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05855746
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05855746. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-16 (actual); primary completion 2028-01-16 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine Versus Placebo in Acute Myocarditis Patients
Acronym
ARGO
Condition
Acute Myocarditis
Intervention (Drug)
Colchicine Pill
Intervention (Drug)
Placebo
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)
Collaborator
Hospices Civils de Lyon (class: other)
Collaborator
Fonds de Dotation ACTION (class: other)

Record details

Record id
cardio:ct-nct05855746
Content hash
54f011d39cc4f8d2b8930ecab9a5df093ccf8080e5c6dd9676ccf4cda4317ebf